口腔用薄膜フィルム市場の規模、シェア、成長分析、製品別、適応疾患別、流通チャネル別、地域別 - 産業予測、2025～2032年

口腔用薄膜フィルムの世界市場規模は2023年に34億6,000万米ドルと評価され、2024年の37億8,000万米ドルから2032年には77億米ドルに成長し、予測期間（2025-2032年）のCAGRは9.3％で成長する見通しです。

世界の口腔用薄膜フィルム市場は、経口ドラッグデリバリーを強化する溶解可能なストリップの生産を特徴とする製薬業界の重要な分野として台頭しています。これらのフィルムは、従来の錠剤やカプセルに代わる便利で患者中心の選択肢を提供し、特に小児や老人の集団に対して、投与の容易さ、正確な投与量、患者のコンプライアンスを向上させています。革新的なドラッグデリバリーシステムに対する需要が市場の成長を後押しする一方で、複雑な製造工程、規制上のハードル、確立された剤形との競合といった課題は依然として残っています。とはいえ、個別化医療、小児医療、自己投与療法、栄養補助食品分野での応用拡大など、ビジネスチャンスは豊富にあり、口腔用薄膜フィルムは進化するヘルスケア展望における重要な企業として位置づけられています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩

口腔用薄膜フィルム市場規模：製品別

• 市場概要
• 舌下フィルム
• 速溶性デンタル/バッカルフィルム

口腔用薄膜フィルム市場規模：適応疾患別

• 市場概要
• 統合失調症
• 片頭痛
• オピオイド依存症
• 吐き気と嘔吐
• その他

口腔用薄膜フィルム市場規模：流通チャネル別

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局

口腔用薄膜フィルム市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Pfizer Inc.（USA）
• Novartis International AG（Switzerland）
• Merck & Co., Inc.（USA）
• Sanofi S.A.（France）
• GlaxoSmithKline plc（UK）
• Johnson & Johnson（USA）
• Bayer AG（Germany）
• Eli Lilly and Company（USA）
• AbbVie Inc.（USA）
• AstraZeneca plc（UK）
• Sumitomo Dainippon Pharma Co., Ltd.（Japan）
• Indivior PLC（UK）
• BioDelivery Sciences International, Inc.（USA）
• Aquestive Therapeutics, Inc.（USA）
• IntelGenx Technologies Corp.（Canada）
• Tesa Labtec GmbH（Germany）
• CURE Pharmaceutical Holding Corp.（USA）
• ZIM Laboratories Limited（India）
• NAL Pharma（UK）

結論と推奨事項

Global Oral Thin Films Market size was valued at USD 3.46 billion in 2023 and is poised to grow from USD 3.78 billion in 2024 to USD 7.7 billion by 2032, growing at a CAGR of 9.3% during the forecast period (2025-2032).

The global oral thin films market is emerging as a vital area of the pharmaceutical industry, characterized by the production of dissolvable strips that enhance oral drug delivery. These films offer a convenient and patient-centric alternative to traditional tablets and capsules, improving ease of administration, accurate dosage, and patient compliance, particularly for pediatric and geriatric populations. While the demand for innovative drug delivery systems propels market growth, challenges such as the complex manufacturing processes, regulatory hurdles, and competition from established dosage forms persist. Nevertheless, opportunities abound in personalized medicine, pediatric needs, and self-administered therapies, as well as expanding applications in the nutraceutical sector, positioning oral thin films as a significant player in the evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oral Thin Films market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oral Thin Films Market Segmental Analysis

Global Oral Thin Films Market is segmented by Product, Disease Indication, Distribution Channel and region. Based on Product, the market is segmented into Sublingual Film and Fast Dissolving Dental/Buccal Film. Based on Disease Indication, the market is segmented into Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oral Thin Films Market

A significant factor propelling the Global Oral Thin Films market is the rising patient preference for non-invasive drug delivery systems. In 2022, an increasing number of patients favored oral thin films over conventional oral medications like tablets and injections, appreciating their convenience and user-friendliness. The quick disintegration and ease of administration associated with these films enhance medication compliance, making them an attractive option for many. Additionally, the COVID-19 pandemic heightened awareness of safety in healthcare practices, further boosting the demand for non-invasive delivery methods. Consequently, the shift towards oral thin films as a preferred choice in medication delivery is becoming more pronounced.

Restraints in the Global Oral Thin Films Market

In 2022, one of the major obstacles impacting the global oral thin films market was the intricate manufacturing processes tied to these specialized dosage forms. The production and scaling of oral thin films necessitate advanced technology, specialized knowledge, and stringent quality assurance measures. This complexity not only raises manufacturing costs but also restricts the accessibility and affordability of oral thin films for consumers. As a result, these factors collectively pose challenges to market expansion, potentially stifling innovation and limiting the reach of these products in the healthcare sector. Consequently, addressing these manufacturing hurdles is crucial for fostering market growth.

Market Trends of the Global Oral Thin Films Market

The Global Oral Thin Films market is currently influenced by a notable trend characterized by the challenges posed by complex manufacturing processes. As of 2022, these intricate production requirements have emerged as a significant restraint, demanding advanced equipment and specialized expertise, thereby resulting in higher associated costs. This complexity hampers not only the scalability of oral thin films but also their affordability, potentially stunting market growth. Consequently, while there is a growing demand for innovative and convenient drug delivery systems, the barriers posed by manufacturing intricacies are prompting industry players to pursue technological advancements and streamlined processes to enhance production efficiency and market accessibility.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Oral Thin Films Market Size by Product & CAGR (2025-2032)

• Market Overview
• Sublingual Film
• Fast Dissolving Dental/Buccal Film

Global Oral Thin Films Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Schizophrenia
• Migraine
• Opioid Dependence
• Nausea & Vomiting
• Others

Global Oral Thin Films Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Oral Thin Films Market Size & CAGR (2025-2032)

• North America (Product, Disease Indication, Distribution Channel)
  • US
  • Canada
• Europe (Product, Disease Indication, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Disease Indication, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Disease Indication, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Disease Indication, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioDelivery Sciences International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aquestive Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IntelGenx Technologies Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tesa Labtec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CURE Pharmaceutical Holding Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZIM Laboratories Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NAL Pharma (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations